Document is current
Any future updates will be listed below
-
Authors
Bazdyrev, Evgeny http://orcid.org/0000-0002-3023-6239
Panova, Maria http://orcid.org/0000-0002-0778-2389
Brachs, Maria http://orcid.org/0000-0001-9255-5131
Smolyarchuk, Elena http://orcid.org/0000-0002-2615-7167
Tsygankova, Daria http://orcid.org/0000-0001-6136-0518
Gofman, Liudmila http://orcid.org/0000-0001-6867-5694
Abdyusheva, Yana http://orcid.org/0000-0002-2611-8133
Novikov, Fedor http://orcid.org/0000-0001-5343-7722
-
Funding
Funding for this research was provided by:
pharmenterprises
- License Information
-
More Information
Article History
Received: 14 July 2022
Accepted: 21 September 2022
First Online: 3 November 2022
Declarations
:
: The authors declare that they have no conflicts of interest.
: COVID-TRE-03 was approved for all Russian centers by the National Ministry of Health on August 6th, 2020 (registry number 412/2020). The clinical study protocol and the informed consent form were approved by independent ethics committee and the study was done in accordance with the ethical principles of Good Clinical Practice and the Declaration of Helsinki. All participation in the study signed an informed consent in the prescribed form by the ethical committee of the Ministry of Health of the Russian Federation.
